首页> 美国卫生研究院文献>Osteoporosis and Sarcopenia >Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study

【2h】

Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study

机译：日本类风湿关节炎患者与骨质疏松症药物使用相关的因素：风湿病研究所类风湿关节炎队列研究的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

This study aimed to evaluate factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis (RA).

机译：这项研究旨在评估与日本类风湿性关节炎（RA）患者使用骨质疏松症药物相关的因素。

著录项

期刊名称 Osteoporosis and Sarcopenia
作者
Masanori Nakayama; Takefumi Furuya; Eisuke Inoue; Eiichi Tanaka; Katsunori Ikari; Atsuo Taniguchi; Hisahi Yamanaka; Masayoshi Harigai;
展开▼
作者单位

展开▼
年(卷),期 2020(6),2
年度 2020
页码 -1
总页数 6
原文格式 PDF
正文语种
中图分类外科学;
关键词
Antiresorptive agents; Japanese; Osteoporosis; Rheumatoid arthritis;

机译：抗吸收剂;日本人;骨质疏松症;类风湿关节炎;

相似文献

外文文献
中文文献
专利

1. Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study [J] . Masanori Nakayama, Takefumi Furuya, Eisuke Inoue, Osteoporosis and Sarcopenia . 2020,第2期

机译：与日本类风湿性关节炎患者骨质疏松药物用途相关的因素：风湿病类风湿性关节炎队列研究所的结果
2. A GC polymorphism associated with serum 25-hydroxyvitamin D level is a risk factor for hip fracture in Japanese patients with rheumatoid arthritis: 10-year follow-up of the Institute of Rheumatology, Rheumatoid Arthritis cohort study [J] . YoshidaS., IkariK., FuruyaT., Arthritis research & therapy. . 2014,第2期

机译：类风湿关节炎队列研究的十年随访结果显示，与血清25-羟基维生素D水平相关的GC多态性是日本类风湿关节炎患者髋部骨折的危险因素
3. A GC polymorphism associated with serum 25-hydroxyvitamin D level is a risk factor for hip fracture in Japanese patients with rheumatoid arthritis: 10-year follow-up of the Institute of Rheumatology, Rheumatoid Arthritis cohort study [J] . Shinji Yoshida, Katsunori Ikari, Takefumi Furuya, Arthritis Research . 2014,第2期

机译：类风湿关节炎队列研究的十年随访结果显示，与血清25-羟基维生素D水平相关的GC多态性是日本类风湿关节炎患者髋部骨折的危险因素
4. Antiresorptive effect of denosumab in the treatment of osteoporosis in patients with rheumatoid arthritis [C] . M. A. Korolev, N. E. Banshchikova, E. A. Letjagina, 2017 International Multi-Conference on Engineering, Computer and Information Sciences . 2017

机译：地诺单抗对类风湿关节炎骨质疏松症的抗吸收作用
5. Medication Utilization for Rheumatoid Arthritis Among Commercially Insured Patients [D] . Reidt, Shannon. 2020

机译：商业保险患者中类风湿性关节炎的药物利用
6. A GC polymorphism associated with serum 25-hydroxyvitamin D level is a risk factor for hip fracture in Japanese patients with rheumatoid arthritis: 10-year follow-up of the Institute of Rheumatology Rheumatoid Arthritis cohort study [O] . Shinji Yoshida, Katsunori Ikari, Takefumi Furuya, 2014

机译：类风湿关节炎队列研究的十年随访结果显示与血清25-羟基维生素D水平相关的GC多态性是日本类风湿关节炎患者髋部骨折的危险因素
7. Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study [O] . Masanori Nakayama, Takefumi Furuya, Eisuke Inoue, 2020

机译：与日本类风湿性关节炎患者骨质疏松药物用途相关的因素：风湿病类风湿性关节炎队列研究所的结果

Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort study

摘要

著录项

相似文献

相关主题

期刊订阅